Qiqi Xie
Postdoctoral Research Associate
MD, Nanchang University, Jiangxi, China
MS, Orthopedics, Lanzhou University, Gansu, China
Other professional appointments
- Editorial Board Member, Scientific Reports
- Appointed Ambassador, Bentham Science Publishers
Research focus
Multi-agent artificial intelligence for complex biomedical problems, large-scale transcriptomics data analysis, cellular systems behavior, and disease modeling.
Honors and Awards
- National Scholarships, Lanzhou University (2018)
- Outstanding Graduates, Lanzhou University (2018)
- The First-Prize Scholarship, Lanzhou University (2018)
- The Third-Prize Scholarship, Lanzhou University (2016)
- The Second-Prize Scholarship, Nanchang University (2012)
Publications & Papers
Multi-omics analysis identifies glioblastoma dependency on H3K9me3 methyltransferase activity. npj Precis. Onc. (2025)
SUV39H1 maintains cancer stem cell chromatin state and properties in glioblastoma. JCI Insight. (2025)
Expression of matrix metalloproteinases and their association with clinical characteristics of solid tumors. Gene. (2023)
A four-methylated LncRNA signature predicts survival of osteosarcoma patients based on machine learning. Genomics. (2021)
An immune-related gene signature for determining Ewing sarcoma prognosis based on machine learning. J. Cancer Res. Clin. Oncol. (2021)
Development of a Machine Learning-Based Autophagy-Related lncRNA Signature to Improve Prognosis Prediction in Osteosarcoma Patients. Front. Mol. Biosci. (2020)
GRB10 and E2F3 as Diagnostic Markers of Osteoarthritis and Their Correlation with Immune Infiltration. Diagnostics. (2020)
Decreased Expression of NUSAP1 Predicts Poor Overall Survival in Cervical Cancer. J. Cancer. (2020)
Development of a novel immune-related genes prognostic signature for osteosarcoma. Sci. Rep. (2018)
An Immune-Related Long Non-Coding RNA Signature to Predict the Prognosis of Ewing’s Sarcoma... Front. Cell Dev. Biol. (2018)
Presentations
Speaker, Chinese Orthopaedic Association Annual Congress, Xiamen, China (2018)
Attendee, Annual Meeting of the Chinese Society of Clinical Oncology (CSCO), Guangzhou, China (2021)
Participant, National Symposium on Cancer Systems Biology, Shanghai, China (2022)
Attendee, Symposium on Single-Cell Sequencing and Spatial Transcriptomics, Hangzhou, China (2022)
Participant, Precision Medicine and Tumor Immunotherapy Conference, Nanjing, China (2023)